Drug Approval | July 02, 2022
Ascentage Pharma gets IND clearance by the US FDA for novel EED Inhibitor APG-5918
This multicenter, open-label Phase I study is designed to assess the safety and tolerability
This multicenter, open-label Phase I study is designed to assess the safety and tolerability
National Institute of Biologicals should undertake the testing of more biologicals and also extend its testing expertise in helping other countries
A newly revealed mechanism by Weizmann Institute of Science of ketamine’s action on potassium channels in neurons may lead to improved therapies for depression
We must try to make the health care system more accessible for people with disabilities
States were also strongly advised to strictly monitor epidemiological profile of admitted COVID patients
Doctors will study for a Master of Surgery or Master of Medicine degree at Edge Hill University.
The Minister lauded and extended his gratitude to the scientists who developed the vaccine during pandemic.
HIL has set up the Bti bio-larvicide manufacturing facility at its Rasayani Plant at Maharashtra with the financial assistance of GEF/UNIDO under the project
First and only PARP inhibitor to improve invasive disease-free survival in patients
73% have cited fears like losing eyesight, painful procedure or long recovery period when it comes to cataract surgeries
Subscribe To Our Newsletter & Stay Updated
